Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€149.26
07.04.24
-
-
07.04.24

WatchMen 
07.04.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€25.61
02.04.24
€40.00
25.03.25
-3.98%
09.04.24

WatchMen 
02.04.24 50%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€531.40
27.03.24
-
27.04.24
0.87%
02:15

MBU 
27.03.24 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€25.30
25.03.24
-
25.03.25
1.21%
02.04.24

WatchMen 
25.03.24 50%
buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€149.26
25.03.24
-
-
25.03.24

WatchMen 
25.03.24 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€136.44
22.03.24
-
-
22.03.24

WatchMen 
22.03.24 50%
sell
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.92
19.03.24
-
-
19.03.24

WatchMen 
19.03.24 50%
sell
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€48.90
06.03.24
-
06.03.25
-1.74%
16.03.24

nero 
06.03.24 0%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€45.45
08.02.24
-
08.03.24
8.36%
09.03.24

Rastapopolus 
08.02.24 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.90
03.02.24
-
03.02.25
4.61%
02.03.24

knallfrosch44665 
03.02.24 60%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€41.92
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€451.50
26.01.24
-
26.02.24
7.31%
27.02.24

Tonau 
26.01.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.05
07.01.24
-
07.02.24
-5.36%
08.02.24

fabudagga 
07.01.24 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
05.01.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€557.00
03.01.24
-
03.02.24
12.39%
04.02.24

Paul 
03.01.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
02.01.24 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.50
25.12.23
-
25.12.24
6.04%
05.01.24

fenjal 
25.12.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€69.02
13.12.23
€75.00
04.04.24
25.47%
25.03.24

RudolfL 
13.12.23 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€357.30
13.12.23
€396.00
04.07.24
10.15%
24.01.24

RudolfL 
13.12.23 50%
sell
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€496.50
09.12.23
-
09.12.24
2.24%
23.12.23

KongVestor 
09.12.23 50%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€168.10
04.12.23
€184.00
21.06.24
-15.98%
12.04.24

RudolfL 
04.12.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€26.65
04.12.23
-
04.01.24
-0.19%
05.01.24

fabudagga 
04.12.23 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€8.65
02.12.23
-
02.01.24
19.08%
03.01.24

fabudagga 
02.12.23 50%